Linked from

The 51 pages that link to Type 2 diabetes, each with the reason it gives.

• ObesityRelated: It is a major obesity-associated condition, though obesity does not make it inevitable.

• Physical activityRelated: Physical activity improves glucose regulation and helps reduce disease risk.

• Mediterranean dietRelated: Studies associate Mediterranean-style eating with improved diabetes risk and management.

• GluconeogenesisRelated: Excess hepatic glucose production, including gluconeogenesis, contributes to hyperglycemia.

• Insulin resistanceRelated: Persistent resistance increases the secretory burden on beta cells and contributes to disease.

• StatinRelated: Statins slightly increase diabetes risk, especially in people already predisposed.

• Polycystic ovary syndromeRelated: PCOS is associated with increased risk, making metabolic screening relevant to ongoing care.

• Diabetic ketoacidosisRelated: Severe insulin deficiency during stress can also produce ketoacidosis in type 2 diabetes.

• Endothelial dysfunctionRelated: Hyperglycemia and insulin resistance can impair endothelial nitric oxide signaling.

• MetforminRelated: This is the principal condition for which metformin is prescribed.

• Insulin therapyRelated: Insulin may be added when other treatments do not adequately control glucose.

• Ketogenic DietRelated: Carbohydrate restriction may affect glucose control, but treatment changes require medical oversight.

• Plant-based dietRelated: Dietary patterns rich in plant foods are used in prevention and management research.

• Brown adipose tissueRelated: Brown-fat glucose uptake has prompted research into its potential relevance to glucose control.

• AMP-activated protein kinaseRelated: AMPK’s effects on glucose and lipid metabolism make it relevant to diabetes research and treatment.

• GLP-1 receptor agonistRelated: GLP-1 receptor agonists lower glucose and can reduce cardiovascular risk in selected patients.

• Insulin secretionRelated: Declining beta-cell secretion contributes to worsening glucose control in the disease.

• Added sugarRelated: High intake of sugar-sweetened beverages is associated with increased risk, though sugar alone does not explain the disease.

• Pancreatic isletRelated: Islet beta cells may fail to meet the body’s increased insulin demand.

• Bariatric surgeryRelated: Bariatric procedures can improve diabetes, sometimes before major weight loss occurs.

• Intermittent fastingRelated: Fasting schedules may affect glucose control and require medication-aware clinical guidance.

• SulfonylureaRelated: Sulfonylureas are used when additional glucose lowering is needed.

• Glucagon-like peptide-1Related: GLP-1-based therapies improve glucose control in this disease.

• Sedentary behaviorRelated: Prolonged sedentary time is linked to diabetes risk through metabolic pathways.

• Beta-glucanRelated: Viscous beta-glucan can reduce the rise in blood glucose after meals.

• Bardet–Biedl syndromeRelated: It can develop alongside obesity and requires attention in long-term syndrome care.

• OlanzapineRelated: Olanzapine can raise blood glucose and increase diabetes risk, particularly alongside weight gain.

• AdipokineRelated: Adipokine effects on insulin sensitivity connect adipose biology to this disease.

• Human nutritionRelated: Diet is one influence among the interacting causes and management factors.

• LiraglutideRelated: Liraglutide improves glycemic control in adults with this disease.

• SemaglutideRelated: Semaglutide is prescribed to improve glycemic control in this disease.

• Gila monsterRelated: Exenatide, developed from a Gila monster peptide, is used to manage this disease.

• SugarRelated: Sugar intake affects blood glucose, but diabetes risk is shaped by broader factors.

• Alström syndromeRelated: It is a frequent later metabolic complication requiring ongoing care.

• BerberineRelated: Trials have examined berberine as an adjunct for controlling blood glucose in this condition.

• Non-alcoholic fatty liver diseaseRelated: It is a frequent comorbidity and increases risk of progressive liver injury.

• ResveratrolRelated: Resveratrol has been studied for effects on glucose regulation, but it is not an established treatment.

• Werner syndromeRelated: It is a common metabolic complication of Werner syndrome.

• Diabetes medicationRelated: Multiple medication classes address its changing combination of insulin resistance and inadequate secretion.

• GlibenclamideRelated: Glibenclamide is used to improve glycemic control in this form of diabetes.